| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/13/2011 | WO2011127418A1 Btnl9 proteins, nucleic acids, and antibodies and uses thereof |
| 10/13/2011 | WO2011127324A2 Antibodies to cd122 |
| 10/13/2011 | WO2011127302A2 Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems |
| 10/13/2011 | WO2011127141A1 TNF-α BINDING PROTEINS |
| 10/13/2011 | WO2011127032A1 Compositions and methods related to protein a (spa) antibodies as an enhancer of immune response |
| 10/13/2011 | WO2011126976A1 Reovirus vaccines and methods of use therefor |
| 10/13/2011 | WO2011126863A1 Factor h binding proteins (fhbp) with altered properties and methods of use thereof |
| 10/13/2011 | WO2011126833A2 Anti-inflammatory factors |
| 10/13/2011 | WO2011126576A2 Genetic signatures in the envelope glycoprotein of hiv-1 |
| 10/13/2011 | WO2011126370A1 Recombinant multimeric influenza proteins |
| 10/13/2011 | WO2011125469A1 Micro-rna-regulated recombinant vaccinia virus and utilization thereof |
| 10/13/2011 | WO2011125331A1 Metal salen complex derivative and process for production thereof |
| 10/13/2011 | WO2011125139A1 Cluap1 peptides and vaccines including the same |
| 10/13/2011 | WO2011124931A1 Immune modulation |
| 10/13/2011 | WO2011124635A1 Binding molecules against chikungunya virus and uses thereof |
| 10/13/2011 | WO2011124056A1 Genetically engineered vaccine against lymphocystis disease in paralichthys olivaceus and method for producing the same |
| 10/13/2011 | WO2011123945A1 Compostions, methods and uses for treating respiratory syncytial virus infection |
| 10/13/2011 | WO2011123903A1 Chemokine receptor heteromultimers, compounds that bind thereto and uses thereof |
| 10/13/2011 | WO2011123900A1 Methods and compositions for inhibiting hiv transmission |
| 10/13/2011 | WO2011106707A3 Antibodies that specifically bind to dr3 |
| 10/13/2011 | WO2011094363A3 Influenza virus compositions and methods for universal vaccines |
| 10/13/2011 | WO2011091304A9 Delivery system for diagnostic and therapeutic agents |
| 10/13/2011 | WO2011075806A3 Lentivirus vaccine based on the recombinant viral vaccine against yellow fever |
| 10/13/2011 | WO2011067758A3 Immunogenic fragments and multimers from streptococcus pneumoniae proteins |
| 10/13/2011 | WO2011056721A3 Immunoconjugates comprising poxvirus-derived peptides and antibodies against antigen-presenting cells for subunit-based poxvirus vaccines |
| 10/13/2011 | WO2011052906A3 Use of eif3m for the diagnosis and treatment of cancer |
| 10/13/2011 | WO2011049412A3 Human recombinant monoclonal antibody that specifically binds to vcam-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells |
| 10/13/2011 | WO2011047794A3 Medical utility of glycan-binding proteins and glycans |
| 10/13/2011 | WO2011046996A3 Consensus sequence for influenza a virus |
| 10/13/2011 | WO2010103284A8 Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gene |
| 10/13/2011 | US20110251141 Composition for topical treatment of mixed vaginal infections |
| 10/13/2011 | US20110251136 Glue composition for lung volume reduction |
| 10/13/2011 | US20110250693 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 10/13/2011 | US20110250650 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 10/13/2011 | US20110250267 Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions |
| 10/13/2011 | US20110250265 Vaccine Preparation for Neospora Caninum Infection |
| 10/13/2011 | US20110250259 Method of treating and preventing breast diseases and breast cancer with medicated formula |
| 10/13/2011 | US20110250258 Tumor-specific delivery of therapeutic agents via liposomase |
| 10/13/2011 | US20110250237 Immunogenic amphipathic peptide compositions |
| 10/13/2011 | US20110250234 Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof |
| 10/13/2011 | US20110250233 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 10/13/2011 | US20110250232 DNA-Transfection System for the Generation of Infectious Influenza Virus |
| 10/13/2011 | US20110250231 Method of using punicic acid to enhance immune response and prevent metabolic disorders |
| 10/13/2011 | US20110250230 Cell capable of expressing exogenous gitr ligand |
| 10/13/2011 | US20110250229 Allogeneic cancer cell-based immunotherapy |
| 10/13/2011 | US20110250228 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin |
| 10/13/2011 | US20110250225 Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| 10/13/2011 | US20110250224 Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines |
| 10/13/2011 | US20110250223 Hybrid and tandem expression of neisserial proteins |
| 10/13/2011 | US20110250222 Antigenic polypeptides of chlamydia-related bacteria for diagnosis and vaccine |
| 10/13/2011 | US20110250221 Group A Streptococcus Pharmaceutical Compositions and Methods Thereof |
| 10/13/2011 | US20110250220 Modified gp140 envelope polypeptides of hiv-1 isolates, compositions, stabilized trimeric complexes, and uses thereof |
| 10/13/2011 | US20110250219 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides |
| 10/13/2011 | US20110250218 Disease-Associated Antigens and Methods of Use Thereof |
| 10/13/2011 | US20110250217 Methods and compositions for eliciting an amyloid-selective immune response |
| 10/13/2011 | US20110250216 Methods for killing psma-expressing, taxane-resistant cancer cells |
| 10/13/2011 | US20110250215 Structurally-related relaxin-fusion proteins with extended in vivo half-lives |
| 10/13/2011 | US20110250214 Drug delivery system toward demyelinating lesion and biochemical marker of demyelinating lesion |
| 10/13/2011 | US20110250213 Antibodies to cd122 |
| 10/13/2011 | US20110250212 Therapy procedure for drug delivery for trigeminal pain |
| 10/13/2011 | US20110250211 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins |
| 10/13/2011 | US20110250210 Neutralizing Antibodies and Fragments Thereof Directed Against Platelet Factor-4 Variant 1 (PF4V1) |
| 10/13/2011 | US20110250209 Inhibition of plgf to treat philadelphia chromosome positive leukemia |
| 10/13/2011 | US20110250208 Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor |
| 10/13/2011 | US20110250207 Anti-fxi antibodies and methods of use |
| 10/13/2011 | US20110250206 Markers for determination of patient responsiveness |
| 10/13/2011 | US20110250205 Anti-sclerostin antibodies |
| 10/13/2011 | US20110250204 Methods and compositions for diagnosing and treating diseases |
| 10/13/2011 | US20110250203 Anti-cd5 antibodies |
| 10/13/2011 | US20110250202 Reagents, methods, and systems for detecting methicillin-resistant staphylococcus |
| 10/13/2011 | US20110250201 Antagonists of il-6 to raise albumin and/or lower crp |
| 10/13/2011 | US20110250200 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
| 10/13/2011 | US20110250199 Immunotoxins and uses thereof |
| 10/13/2011 | US20110250198 ActRIIB FUSION POLYPEPTIDES AND USES THEREFOR |
| 10/13/2011 | US20110250197 Pharmaceutical combination |
| 10/13/2011 | US20110250196 Pharmaceutical composition using gonadotropin - releasing hormone (gnrh) combined variants as immunogen |
| 10/13/2011 | US20110250195 Antibodies Against IL-25 |
| 10/13/2011 | US20110250194 Treatment with Anti-ErbB2 Antibodies |
| 10/13/2011 | US20110250193 Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease |
| 10/13/2011 | US20110250174 Stable immunogenic product comprising antigenic heterocomplexes |
| 10/13/2011 | US20110250172 Hepatitis c virus inhibitors |
| 10/13/2011 | US20110250171 Compositions and Methods for Cancer Immunotherapy |
| 10/13/2011 | US20110250168 Sialoadhesin-related compositions and methods |
| 10/13/2011 | US20110250167 Method for purifying proteins |
| 10/13/2011 | US20110250166 Combination of rocaglamide and apoptosis inducing substances for the treatment of cancer |
| 10/13/2011 | US20110250165 Antibodies against CXCR4 and Methods of Use Thereof |
| 10/13/2011 | US20110250134 Sustained release nitric oxide from long lived circulating nanoparticles |
| 10/13/2011 | US20110250132 Lipoic acid metabolite: useful for drug carrier, nanoparticle conjugate, imaging and hyperthermia therapy |
| 10/13/2011 | US20110250131 Antigens Associated with Endometriosis, Psoriatic Arthritis and Psoriasis |
| 10/13/2011 | US20110250130 Tnf-alpha binding proteins |
| 10/13/2011 | CA2795853A1 Methods and compositions for inhibiting hiv transmission |
| 10/13/2011 | CA2795789A1 Btnl9 proteins, nucleic acids, and antibodies and uses thereof |
| 10/13/2011 | CA2795734A1 Tnf-.alpha. binding proteins |
| 10/13/2011 | CA2795695A1 Microrna-controlled recombinant vaccinia virus and use thereof |
| 10/13/2011 | CA2795423A1 Cluap1 peptides and vaccines including the same |
| 10/13/2011 | CA2795279A1 Antibodies to cd122 |
| 10/13/2011 | CA2790167A1 Factor h binding proteins (fhbp) with altered properties and methods of use thereof |
| 10/12/2011 | EP2374894A2 A method for producing influenza hemagglutinin multivalent vaccines |
| 10/12/2011 | EP2374892A2 Expression of viral proteins in plants |
| 10/12/2011 | EP2374889A2 Novel compounds |